Sales numbers growing strongly (albeit off low bases) so that's the positive.
My concern is that on a quarterly cash burn of $500k, and with only $1.2m in the bank to fund operating activities, unless sales start drastically reducing cash burn, we will have to equity raise prior to end of FY 22, which would dilute holdings.
- Forums
- ASX - By Stock
- DMC
- Ann: Q1 FY22 Business Update and Appendix 4C
Ann: Q1 FY22 Business Update and Appendix 4C, page-2
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add DMC (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, MD & CEO
James Graham
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online